RNATICS GmbH
🇩🇪Germany
Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers.
Phase 1
Recruiting
- Conditions
- Healthy VolunteersSafetyTolerabilityPharmacokinetics
- Interventions
- Drug: Placebo (in SAD)Drug: Placebo (MAD)Drug: RCS-21 (in MAD)Drug: RCS-21 (in SAD)
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- RNATICS GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT06752122
- Locations
- 🇩🇪
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany
© Copyright 2025. All Rights Reserved by MedPath